• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meta-Analysis of Atrial Fibrillation in Patients With COVID-19.

作者信息

Yang Haiyan, Liang Xuan, Xu Jie, Hou Hongjie, Wang Yadong

机构信息

Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.

Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.

出版信息

Am J Cardiol. 2021 Apr 1;144:152-156. doi: 10.1016/j.amjcard.2021.01.010. Epub 2021 Jan 27.

DOI:10.1016/j.amjcard.2021.01.010
PMID:33508269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7839388/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7839388/02ab56400a2d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7839388/02ab56400a2d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f992/7839388/02ab56400a2d/gr1_lrg.jpg

相似文献

1
Meta-Analysis of Atrial Fibrillation in Patients With COVID-19.新型冠状病毒肺炎患者心房颤动的Meta分析
Am J Cardiol. 2021 Apr 1;144:152-156. doi: 10.1016/j.amjcard.2021.01.010. Epub 2021 Jan 27.
2
Fulminant myocarditis and atrial fibrillation in child with acute COVID-19.儿童急性 COVID-19 合并暴发性心肌炎和心房颤动。
J Electrocardiol. 2022 Jul-Aug;73:150-152. doi: 10.1016/j.jelectrocard.2020.10.004. Epub 2020 Oct 18.
3
In response to: preventing atrial fibrillation in COVID-19: exploring the role of interleukin-6 receptor antagonists.回应：预防新冠病毒肺炎中的心房颤动：探索白细胞介素-6受体拮抗剂的作用
Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(10):715-716. doi: 10.1080/14779072.2023.2264761. Epub 2023 Oct 26.
4
Interatrial block, atrial fibrillation, and thrombotic events in COVID-19.新型冠状病毒肺炎中的房间隔阻滞、心房颤动和血栓形成事件
Eur J Clin Invest. 2022 Aug;52(8):e13800. doi: 10.1111/eci.13800. Epub 2022 May 4.
5
The detrimental interplay between atrial fibrillation and COVID-19: new evidence and unsolved questions.心房颤动与2019冠状病毒病之间的有害相互作用：新证据与未解决的问题。
Acta Cardiol. 2024 May;79(3):410-412. doi: 10.1080/00015385.2024.2313938. Epub 2024 Feb 9.
6
Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen?新冠病毒肺炎中的心房颤动：治疗靶点还是不祥之兆？
Heart Lung Circ. 2021 Aug;30(8):1114-1116. doi: 10.1016/j.hlc.2021.06.001.
7
The impact of atrial fibrillation on outcomes in patients hospitalized with COVID-19.心房颤动对COVID-19住院患者预后的影响。
Eur J Intern Med. 2023 May;111:127-129. doi: 10.1016/j.ejim.2023.01.017. Epub 2023 Jan 25.
8
COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?-An Insight from the GeroCovid Registry.COVID-19 和老年患者的心房颤动：口服抗凝治疗是否提供生存获益？——来自 GeroCovid 登记处的见解。
Thromb Haemost. 2022 Jan;122(1):105-112. doi: 10.1055/a-1503-3875. Epub 2021 Jun 18.
9
Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.远程医疗在心房颤动抗凝管理中的作用：一种实用的临床方法。
Future Cardiol. 2022 Sep;18(9):743-754. doi: 10.2217/fca-2022-0044. Epub 2022 Jul 13.
10
COVID-19: another reason for anticoagulation in patients with atrial fibrillation.新型冠状病毒肺炎：心房颤动患者抗凝治疗的又一原因。
Heart. 2022 May 25;108(12):902-904. doi: 10.1136/heartjnl-2022-320845.

引用本文的文献

1
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据：美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
2
The Trends in Atrial Fibrillation-Related Mortality before, during, and after the COVID-19 Pandemic Peak in the United States.美国在新冠疫情高峰期之前、期间及之后与心房颤动相关的死亡率趋势
J Clin Med. 2024 Aug 15;13(16):4813. doi: 10.3390/jcm13164813.
3
Pre-Existing Atrial Fibrillation in Hospitalized Patients with COVID-19: Insights from the CARDIO COVID 19-20 Registry.

本文引用的文献

1
Relationship between chronic kidney disease and adverse outcomes of coronavirus disease 2019: a meta-analysis based on adjusted risk estimates.慢性肾脏病与2019冠状病毒病不良结局之间的关系：基于调整后风险估计值的荟萃分析
Int Urol Nephrol. 2021 Aug;53(8):1723-1727. doi: 10.1007/s11255-020-02748-9. Epub 2021 Jan 2.
2
Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates.自身免疫性疾病与新冠病毒疾病严重程度独立相关：基于校正效应估计的证据
J Infect. 2021 Apr;82(4):e23-e26. doi: 10.1016/j.jinf.2020.12.025. Epub 2020 Dec 28.
3
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort.
COVID-19住院患者的既往房颤：来自CARDIO COVID 19-20注册研究的见解
J Cardiovasc Dev Dis. 2024 Jul 4;11(7):210. doi: 10.3390/jcdd11070210.
4
Chronic Anticoagulation in Patients with Atrial Fibrillation and COVID-19: A Systematic Review and Meta-Analysis.慢性抗凝治疗在伴有 COVID-19 的心房颤动患者中的应用：系统评价和荟萃分析。
Arq Bras Cardiol. 2024 Apr 26;121(3):e20230470. doi: 10.36660/abc.20230470. eCollection 2024.
5
Atrial fibrillation and COVID-19: an analysis of the ambulatory database.心房颤动与2019冠状病毒病：动态数据库分析
Front Cardiovasc Med. 2024 Apr 16;11:1384826. doi: 10.3389/fcvm.2024.1384826. eCollection 2024.
6
Higher incidence of new atrial fibrillation in hospitalised COVID-19 patients compared to lower respiratory tract infection, however, less patients anticoagulated at discharge.与下呼吸道感染相比，住院的新冠肺炎患者新发房颤的发生率更高，然而，出院时接受抗凝治疗的患者较少。
Future Healthc J. 2023 Nov;10(Suppl 3):5-7. doi: 10.7861/fhj.10-3-s5.
7
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据：美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
8
Higher incidence of new atrial fibrillation in hospitalised COVID-19 patients compared to lower respiratory tract infection, however, less patients prescribed anticoagulants at discharge.与下呼吸道感染相比，住院 COVID-19 患者新发心房颤动的发生率更高，然而，出院时开具抗凝药物的患者较少。
Clin Med (Lond). 2023 Sep;23(5):478-484. doi: 10.7861/clinmed.2023-0188.
9
New-Onset Atrial Fibrillation in the Setting of COVID-19 Infection Is a Predictor of Mortality in Hospitalized Patients: CovAF-Study.COVID-19感染背景下的新发房颤是住院患者死亡率的预测指标：CovAF研究。
J Clin Med. 2023 May 16;12(10):3500. doi: 10.3390/jcm12103500.
10
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.《心脏病与卒中统计数据-2023 更新：美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
来自法国多中心队列的慢性透析患者中 COVID-19 严重程度的风险因素。
Clin Kidney J. 2020 Oct 21;13(5):878-888. doi: 10.1093/ckj/sfaa199. eCollection 2020 Oct.
4
Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases.年龄、性别、合并症及临床症状对新型冠状病毒肺炎病例严重程度的影响：一项纳入55项研究及10014例病例的荟萃分析
Heliyon. 2020 Dec;6(12):e05684. doi: 10.1016/j.heliyon.2020.e05684. Epub 2020 Dec 15.
5
Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.2019 年冠状病毒病的自然史：2600 多万美国医疗保险受益人的住院和死亡风险因素。
J Infect Dis. 2021 Mar 29;223(6):945-956. doi: 10.1093/infdis/jiaa767.
6
Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎患者的性别、年龄及合并症与死亡率的关联：一项系统综述和荟萃分析
Intervirology. 2020 Dec 9:1-12. doi: 10.1159/000512592.
7
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19.开发一种新型风险评分系统，以预测因 COVID-19 住院患者的死亡率。
Sci Rep. 2020 Dec 7;10(1):21379. doi: 10.1038/s41598-020-78505-w.
8
The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates.糖尿病与新冠病毒疾病严重程度的关联：来自调整后效应估计的证据。
Hormones (Athens). 2021 Jun;20(2):409-414. doi: 10.1007/s42000-020-00259-x. Epub 2020 Nov 25.
9
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection.2019冠状病毒病（COVID-19）感染住院患者的冠状动脉疾病
Open Heart. 2020 Nov;7(2). doi: 10.1136/openhrt-2020-001428.
10
Prevalence and clinical correlates of dementia among COVID-19-related deaths in Italy.意大利新冠疫情相关死亡病例中痴呆症的患病率及临床关联因素
Alzheimers Dement (Amst). 2020 Nov 14;12(1):e12114. doi: 10.1002/dad2.12114. eCollection 2020.